HARROW, INC. — Director's Dealing 2013

Mar 16, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-12-31

Reporting Person: Brar Balbir (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-28	Option (Right to Buy)	$3.68	A	225000	Acquired	2016-02-28	Common Stock (225000)	Direct
2012-04-01	Option (Right to Buy)	$4.5	A	25000	Acquired	2017-03-31	Common Stock (25000)	Direct

Footnotes

F1: The stock option was granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests over a three year period, with 1/36th of the total number of options vesting each monthly period beginning on February 23, 2012. The option was approved by the Issuer's Board of Directors on January 23, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.

F2: The stock options were granted under the Plan and vest over a 1 year period, with the initial 6,250 options vesting on June 30, 2012, the next 6,250 options vesting on September 30, 2012, the next 6,250 options vesting on December 31, 2012 and the final 6,250 options vesting on March 31, 2013.